These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus. Stewart LT; Khan AU; Wang K; Pizarro D; Pati S; Buckingham SC; Olsen ML; Chatham JC; McMahon LL J Neurosci; 2017 Aug; 37(34):8207-8215. PubMed ID: 28760863 [TBL] [Abstract][Full Text] [Related]
11. O-GlcNAc modification affects the ATM-mediated DNA damage response. Miura Y; Sakurai Y; Endo T Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405 [TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension. Lima VV; Rigsby CS; Hardy DM; Webb RC; Tostes RC J Am Soc Hypertens; 2009; 3(6):374-87. PubMed ID: 20409980 [TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc signaling in the cardiovascular system. Ngoh GA; Facundo HT; Zafir A; Jones SP Circ Res; 2010 Jul; 107(2):171-85. PubMed ID: 20651294 [TBL] [Abstract][Full Text] [Related]
14. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart. Belke DD J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720 [TBL] [Abstract][Full Text] [Related]
15. O-Glycosylation with O-linked β-N-acetylglucosamine increases vascular contraction: Possible modulatory role on Interleukin-10 signaling pathway. Miguez JSG; Dela Justina V; Bressan AFM; Marchi PGF; Honorio-França AC; Carneiro FS; Clinton Webb R; Tostes RC; Giachini FR; Lima VV Life Sci; 2018 Sep; 209():78-84. PubMed ID: 30075176 [TBL] [Abstract][Full Text] [Related]
16. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Hart GW; Slawson C; Ramirez-Correa G; Lagerlof O Annu Rev Biochem; 2011; 80():825-58. PubMed ID: 21391816 [TBL] [Abstract][Full Text] [Related]
17. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy. Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430 [TBL] [Abstract][Full Text] [Related]
18. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Goldberg H; Whiteside C; Fantus IG Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532 [TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation in health and neurodegenerative diseases. Lee BE; Suh PG; Kim JI Exp Mol Med; 2021 Nov; 53(11):1674-1682. PubMed ID: 34837015 [TBL] [Abstract][Full Text] [Related]